Arcturus Therapeutics Holdings (ARCT) EV to CFO (2022 - 2024)
Arcturus Therapeutics Holdings' (ARCT) EV to CFO came in at 50.81 for Q1 2024, up 643.5% from 6.83 a year earlier.
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) EV to CFO (2022 - 2024) Analysis & Trends
For the trailing twelve months through Mar 31, 2024, EV to CFO at Arcturus Therapeutics Holdings was -25.12; for FY2022, it was 1.83.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Arcturus Therapeutics Holdings | 314.64 Mn | -499.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 50.81 |
| Sep 30, 2023 | 2.60 |
| Jun 30, 2023 | 3.30 |
| Mar 31, 2023 | 6.83 |
| Dec 31, 2022 | 1.83 |
API Access
Arcturus Therapeutics Holdings EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();